Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3
1 clinical trials · Condition
◉ Watch Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3
| Record | Firm | Date |
|---|---|---|
| A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 (NCT04429087) | Boehringer Ingelheim | 2020-07-29 |
Track Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3 automatically
Every clearance here is in the API, with alerts when new ones post.